RSSL can seamlessly diversify a U.S. stock allocation and unlock the long-term growth potential of U.S. small-cap equities.
RSSL provides investors access to a basket of U.S. small-cap equities in a convenient and efficient wrapper.
RSSL's expense ratio is more than 10x below the competitor average.1
1Expense ratio was 91.75% lower than the competitor average net expense ratio as of 4/1/25, per Morningstar (category: “Morningstar Small Blend Fund Category”, inclusive of ETFs & Mutual Funds)
NAV | $79.60 | Daily Change | -$0.22 | -0.28% |
Market Price | $79.58 | Daily Change | -$0.27 | -0.34% |
Fund NAV | Market Price | Index | |
---|---|---|---|
Year-to-Date | -9.48% | -9.46% | -9.48% |
1 Month | -6.81% | -6.72% | -6.81% |
3 Months | -9.48% | -9.46% | -9.48% |
Since Inception | 0.00% | 0.04% | 0.06% |
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
---|---|---|---|---|---|---|
0.68 | SFM | SPROUTS FARMERS | BCGCR79 | 163.43 | 54,740 | 8,946,158.20 |
0.48 | FTAI | FTAI AVIATION LTD | BLKFTK4 | 114.58 | 55,183 | 6,322,868.14 |
0.48 | INSM | INSMED INC | 2614487 | 67.53 | 93,587 | 6,319,930.11 |
0.46 | CRS | CARPENTER TECHNOLOGY | 2177504 | 230.16 | 26,134 | 6,015,001.44 |
0.44 | HIMS | HIMS & HERS HEALTH INC | BN46048 | 54.83 | 105,009 | 5,757,643.47 |
0.38 | IONQ | IONQ INC | BP484B3 | 45.69 | 110,390 | 5,043,719.10 |
0.37 | RKLB | ROCKET LAB USA INC | BM8Z538 | 25.42 | 191,794 | 4,875,403.48 |
0.36 | CRDO | CREDO TECHNOLOGY | BLD13F2 | 61.78 | 76,990 | 4,756,442.20 |
0.35 | SSB | SOUTHSTATE CORP | BNFX071 | 87.60 | 53,161 | 4,656,903.60 |
0.35 | AIT | APPLIED INDU TEC | 2086309 | 222.81 | 20,892 | 4,654,946.52 |
Holdings are subject to change. "Cash" denotes U.S. dollars.
Sector | Weight (%) | |
---|---|---|
Financials | 19.3 | |
Industrials | 17.0 | |
Health Care | 16.9 | |
Information Technology | 14.3 | |
Consumer Discretionary | 9.1 | |
Real Estate | 6.3 | |
Energy | 4.6 | |
Materials | 4.1 | |
Utilities | 3.2 | |
Consumer Staples | 3.0 | |
Communication Services | 2.3 |
Source: AltaVista Research, LLC
All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.
Return on Equity | 8.40% | |
Weighted Avg. Market Cap | 3,337 M | |
2024 | 2025 | |
Price-to-earnings | 27.35 | 22.42 |
Price-to-book value | 1.95 | 1.83 |
Source: AltaVista Research, LLC
* The financial statements include the Fund’s disclosures required by Items 7 through 11 of Form N-CSR, which includes the financial statements, financial highlights, and other important information when applicable.